MARKET

CTLT

CTLT

Catalent Inc
NYSE
37.18
-0.27
-0.72%
After Hours: 37.15 -0.03 -0.08% 16:35 12/08 EST
OPEN
37.21
PREV CLOSE
37.45
HIGH
37.87
LOW
37.11
VOLUME
1.25M
TURNOVER
0
52 WEEK HIGH
74.49
52 WEEK LOW
31.45
MARKET CAP
6.70B
P/E (TTM)
-7.1063
1D
5D
1M
3M
1Y
5Y
Catalent Inc: Annual report
Press release · 23h ago
Catalent Inc: Quarterly report
Press release · 23h ago
Catalent Inc: [Amend]Current report
Press release · 23h ago
S&P 500 Futures Drop In Premarket Trading; GitLab, Core & Main Lead
U.s. Stock markets are set to open in two hours. Gitlab inc. Was up 14.0% in pre-market trading. S&p 500 futures were down 0.34% in early trading. Stocks in asia were down overnight; stocks in europe are mixed.
Barron‘s · 4d ago
Weekly Report: what happened at CTLT last week (1127-1201)?
Weekly Report · 5d ago
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
Jim cramer says vishay intertechnology is "way too cheap" cramer also recommended buying abbott laboratories. Cramer said moelis & company has come down too much and recommended buying the same company.   Cramer was on cnbc's "mad money lightning round"
Benzinga · 11/30 14:26
Catalent Inc: Current report
Press release · 11/27 22:10
Weekly Report: what happened at CTLT last week (1120-1124)?
Weekly Report · 11/27 09:07
More
About CTLT
Catalent, Inc. is engaged in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. The Company’s Biologics segment provides development and manufacturing of biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells (iPSCs); oncolytic viruses, and vaccines. It also provides formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges, and analytical development and testing services for large molecules. The Company’s Pharma and Consumer Health segment comprises capabilities for complex oral solids, softgel formulations, Zydis fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms, and clinical trial development and supply services.

Webull offers Catalent Inc stock information, including NYSE: CTLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTLT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTLT stock methods without spending real money on the virtual paper trading platform.